METHODS: Authors were chosen on the basis of their clinical expertise, familiarity with the peer-reviewed literature, research productivity, and contributions to the neuromodulation literature. Section leaders supervised literature searches of MEDLINE, BioMed Central, Current Contents Connect, Embase, International Pharmaceutical Abstracts, Web of Science, Google Scholar, and PubMed from 2017 (when NACC last published guidelines) to October 2023. Identified studies were graded using the United States Preventive Services Task Force criteria for evidence and certainty of net benefit. Recommendations are based on the strength of evidence or consensus when evidence was scant.
RESULTS: The NACC examined the published literature and established evidence- and consensus-based recommendations to guide best practices. Additional guidance will occur as new evidence is developed in future iterations of this process.
CONCLUSIONS: The NACC recommends best practices regarding the mitigation of complications associated with neurostimulation to improve safety and efficacy. The evidence- and consensus-based recommendations should be used as a guide to assist decision-making when clinically appropriate.
方法:根据作者的临床专业知识选择作者,熟悉同行评审的文献,研究生产力,以及对神经调节文献的贡献。科领导监督MEDLINE的文献检索,BioMedCentral,当前内容连接,Embase,国际医药文摘,WebofScience,谷歌学者,和PubMed从2017年(NACC上次发布指南时)到2023年10月。使用美国预防服务工作组标准对确定的研究进行了分级,以证明净收益的证据和确定性。建议基于证据的强度或证据不足时的共识。
结果:NACC审查了已发表的文献,并建立了基于证据和共识的建议,以指导最佳实践。在此过程的未来迭代中,随着新证据的发展,将出现其他指导。
结论:NACC推荐关于缓解与神经刺激相关的并发症的最佳实践,以提高安全性和疗效。基于证据和共识的建议应用作指导,以在临床上适当时协助决策。